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Abstract  44 
 45 
Background 46 
Impairments in activities of daily living (ADL) are a criterion for Alzheimer’s disease (AD) 47 
dementia. However, ADL gradually decline in AD, impacting on advanced (a-ADL, 48 
complex interpersonal or social functioning), instrumental (IADL, maintaining life in 49 
community), and finally basic functions (BADL, activities related to physiological and self-50 
maintenance needs). Information and communication technologies (ICT) have become an 51 
increasingly important aspect of daily functioning. Yet, the links of ADL, ICT, and 52 
neuropathology of AD dementia are poorly understood. Such knowledge is critical as it can 53 
provide biomarker evidence of functional decline in AD.  54 
Methods 55 
ADL were evaluated with the Technology–Activities of Daily Living Questionnaire (T-56 
ADLQ) in 33 patients with AD and 30 controls. ADL were divided in BADL, IADL, and a-57 
ADL. The three domain subscores were covaried against gray matter atrophy via Voxel-58 
Based Morphometry.  59 
Results 60 
Our results showed that three domain subscores of ADL correlate with several brain 61 
structures, with a varying degree of overlap between them. BADL score correlated mostly 62 
with frontal atrophy, IADL with more widespread frontal, temporal and occipital atrophy 63 
and a-ADL with occipital and temporal atrophy. Finally, ICT subscale was associated with 64 
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atrophy in the precuneus. 65 
Conclusions 66 
The association between ADL domains and neurodegeneration in AD follows a traceable 67 
neuropathological pathway which involves different neural networks. This the first 68 
evidence of ADL phenotypes in AD characterised by specific patterns of functional decline 69 
and well-defined neuropathological changes. The identification of such phenotypes can 70 
yield functional biomarkers for dementias such as AD.  71 
 72 
Keywords: Alzheimer's disease; Functional impairment; Activities of Daily Living; 73 
Technology–Activities of Daily Living Questionnaire. 74 
1. Background 75 
Alzheimer’s disease (AD) is one of the most common form of age-related dementia, 76 
affecting more than 25 million people worldwide, with the number of new cases raising 77 
continuously, both in developed and developing countries [1, 2]. The diagnosis of 78 
dementia due to AD is based on the presence of a gradual onset of cognitive 79 
impairment, mainly an episodic memory impairment with evidence of cognitive 80 
dysfunction in at least one other cognitive domain, whose severity has led to a 81 
significant functional decline in Activities of Daily Living (AD), interfere with the 82 
ability to function at work or at usual activities [3]. 83 
The confirmation of the presence and severity of impairment in ADL is critical for the 84 
diagnosis of dementia[3] . Commonly, ADL have been divided in Basic ADL (BADL) and 85 
Instrumental ADL (IADL). BADL are defined as activities related to basic physiological 86 
and self-maintenance needs, including tasks such as eating, toileting or getting dressed.  87 
IADL include activities, essential to maintain independent living and maintaining 88 
life in community, such as managing finances, shopping, handle medications or using the 89 
public transport [4, 5]. Recently, Advanced ADL (a-ADL) has emerged as an additional 90 
important category in ADL[5, 6]. A-ADL are defined as more complex activities, not being 91 
essential to maintain an independent live, are considered voluntary [7] and include 92 
activities necessary for complex interpersonal or social functioning such as using household 93 
technology, going on holidays, practice hobbies, etc.[4, 6, 8]. A-ADL require higher levels 94 
of cognitive, physical, and social functions, are very sensitive to subtle cognitive 95 
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impairment and could contribute to early diagnosis of dementia[4]. Nonetheless, the 96 
definition of a-ADL and its division from IADL is complex and need to consider cultural 97 
variability, since ADL performance is influenced by cultural events [9-12]. Moreover, as 98 
culture evolves, any scale that is sensitive to early ADL deficits must also evolve to 99 
measure newly relevant activities. 100 
In the last decades, information and communication technologies (ICT) have 101 
become an increasingly important aspect of daily functioning and the use of electronic 102 
devices are essential in different everyday life tasks, such as communication, work or 103 
recreational activities. The use of everyday technology may be of particular concern in 104 
people with dementia because most patients typically continue to live at home, in the same 105 
social context as before the disability and, as a result, they are expected to manage the 106 
everyday technology that is common in that context [13]. ICT could include either IADL 107 
and a-ADL depending on the complexity of the technology and sociocultural factors 108 
shaping technology use [6, 14]. 109 
Despite recent advances in the development of ADL scales, the relationship 110 
between those outcomes and structural brain changes in AD is poorly understood, 111 
especially considering the neural correlates of IADL or BADL. BADL dysfunction in AD 112 
was associated with atrophy in the temporal, cingulate, hippocampus, caudate, frontal, and 113 
parietal regions whereas IADL dysfunction was linked to atrophy in the frontal, temporal, 114 
parietal, insula, and caudate regions[15]. Hippocampal and cortical gray matter volume loss 115 
was associated with rapid IADL decline in AD [16]. Parietal and temporal lobe atrophy at 116 
baseline predict further IADL impairment over time [17].  Finally, PET studies have 117 
reported an association between greater rate of IADL impairment over time and middle 118 
frontal, orbitofrontal and posterior cingulate hypometabolism in AD [18].  119 
However, to our knowledge, there is no study investigating the neural correlates of 120 
a-ADL. Nor is their evidence that such correlates differ from those reported for BADL and 121 
IADL. Moreover, no study has incorporated ICT as an important aspect of functional 122 
assessment. The aim of this study was to investigate the neural correlates of the global 123 
score and subscores of the T-ADQL in patients with AD in comparison to healthy controls 124 
(HC). Specifically, we examined which brain areas were associated with a-ADL 125 
impairment in AD in comparison with BADL and IADL scores. In a first step, total T-126 
ADLQ scores; BADL, IADL and a-ADL subscores were regressed against gray matter 127 
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atrophy via voxel-based morphometry (VBM). In a second step, we performed an inclusive 128 
masking analysis to verify which areas of brain atrophy would overlap between BADL and 129 
a-ADL, and between IADL and a-ADL. Finally, we performed an exclusive masking 130 
analysis to verify areas of brain atrophy displaying no overlap between BADL, a-ADL, and 131 
IADL. We hypothesized that these three ADL domains would exhibit shared and 132 
segregated neuroanatomical substrates and that a-ADL would be associated to regions 133 
involved in more complex cognitive tasks. 134 
2. Methods 135 
2.1 Participants 136 
A cohort comprising 63 participants was recruited for the study. This cohort was 137 
divided into two groups matched according to sex, age, and years of education: 33 subjects 138 
with a clinical diagnosis of AD and 30 healthy controls (HC). Patients were recruited from 139 
the Memory and the Neuropsychiatric Clinic at Hospital del Salvador, and the Neurology 140 
and Neurosurgery Department at Hospital Clínico Universidad de Chile (HCUCH), both 141 
located in Santiago, Chile. HC were recruited from a variety of sources, including spouses 142 
or relatives of patients with dementia. The inclusion criteria considered Spanish-speaking 143 
participants older than 60 years of age. All participants required a reliable proxy who had 144 
known them for at least 5 years. Specifically, a proxy was someone who was able to 145 
provide information about ADL performance, behavioral changes, as well as patients’ 146 
general medical history. The exclusion criteria included illiteracy, underlying neurological 147 
or psychiatric illness that could affect cognition (except AD), physical disability, and 148 
sensory disturbance that could interfere with the neuropsychological assessment. All AD 149 
patients met the NINCDS-ADRDA criteria for probable AD [3]. Diagnosis was made by 150 
consensus between senior neurologists (AS and CD) based on extensive clinical protocol, 151 
interviews with a reliable proxy, laboratory tests and global cognitive functioning. Briefly, 152 
AD patients displayed a history of significant episodic memory loss, within the context of 153 
preserved behavioral and personality, score above 0.5 on the Clinical Dementia Rating 154 
scale (CDR) [3]. HC did not report memory complaints, had a score of 0 on the CDR[3] , 155 
and their cognitive performance was considered normal according to local normative data 156 
for the Addenbrooke’s Cognitive Examination – Revised Chilean Version (ACE-R-Ch)  157 
(>76) [19]. Scores of the T-ADQL were not considered to establish the diagnosis. Ethical 158 
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approval for this study was obtained from the Ethical and Scientific Committee of the East 159 
Metropolitan Health Service and the HCUCH. All the participants, and their caregivers, 160 
provided informed consent in accordance with the Declaration of Helsinki. 161 
2.2 Clinical and Neuropsychological examination  162 
All proxies and participants were interviewed separately in order to obtain the CDR scores. 163 
The T-ADLQ was completed by proxies as we have previously described [20]. Experienced 164 
clinical psychologists trained in the administration of our neuropsychological protocol and 165 
blinded to the diagnosis of each subject carried out the neuropsychological assessment. In 166 
addition to the MMSE [21], and the ACE-R-Ch [19] to assess global cognitive functioning, 167 
the neuropsychological protocol included The Boston Naming Test as an index of naming 168 
abilities. The Rey-Osterrieth Complex Figure Test was used to measured visuospatial 169 
constructional abilities [22]. Forward and backward digit-span tasks provided an index of 170 
working memory while the Word free and cued selective reminding test (FCSRT) was used 171 
to assess episodic memory. The Frontal Assessment Battery (FAB), is a screening test for 172 
executive dysfunction that assesses conceptualization, mental flexibility, motor 173 
programming, resistance to interference, inhibitory control and environmental autonomy, 174 
was also applied[23]. Other tests of executive functions (EF) included the Modified 175 
Version of the Wisconsin Card Sorting Test (MCST) [24] which informs on cognitive 176 
flexibility. Verbal fluency tests including both Phonemic Verbal Fluency test (i.e., words 177 
beginning with letters F, A, and S in one minutes) and Semantic Fluency test (i.e., animals 178 
in 1 minute) as well as the Trail Making Test A and B [25, 26]. 179 
2.3 T-ADLQ 180 
The T-ADLQ [20] consists of 7 subscales: Self-Care, Household Care, Employment 181 
and Recreation, Shopping and Money, Travel and ICT . Each item is rated on a 4-point 182 
scale. For each activities, a rating is provided for instances in which the patient may have 183 
never performed that activity in the past, stopped the activity prior to the onset of dementia, 184 
or for which the proxy did not have information [27].The overall functional impairment 185 
(FI) was calculated for each domain as well as for the global questionnaire as follows: (sum 186 
of all ratings not rated ND/DK)/ (3 x total number of items not rated ND/DK).  The 187 
denominator represents the score that would have been obtained if the most severe level of 188 
impairment had been indicated for all items rated not ND/DK [27]. This equation ensures 189 
that the functional impairment score was based on the actual functioning of the patients 190 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
7 
 
relative to their own premorbid functioning. Higher percentage scores indicate greater 191 
deterioration. 192 
An expert panel (2 neurologists, 3 psychologists, 1 occupational therapist) gathered 193 
the activities of the T-ADLQ in three domains (BADL –IADL – a-ADL).  To ensure 194 
consistency of the division, each expert classified each activity independently and then a 195 
consensus was reached to harmonize the different classifications. The outcomes from the 196 
consensus classification are presented in Table 1. 197 
----- INSERT TABLE 1 BY HERE--------- 198 
2.4 Statistical analyses for demographic and neuropsychological data 199 
The Statistical Package for the Social Sciences (SPSS) version 20 for Windows 200 
(IBM Corp., Armonk, NY, USA) was used to analyze the demographic and 201 
neuropsychological data. We obtained descriptive statistics for such data, used chi-squared 202 
for the categorical variables, and perform two-tailed independent-sample t-tests for the 203 
comparisons between AD and HC. Differences with a p< .05 were considered significant. 204 
Additionally, the effect sizes (Cohen’s-d statistic) were calculated to determine the 205 
magnitude of the group differences. According to Cohen, effect sizes between 0.2 and 0.49 206 
are considered small; those between 0.5 and 0.79, moderate; and those 0.8, large [28]. 207 
2.5 MRI acquisition 208 
MRI acquisition was performed in two 1.5 Tesla MRI scanners, a Philips Intera 209 
Nova Dual gradient system (45mT/m), and a Siemens Symphony Maestro Class (Erlangen, 210 
Germany) with 20 mT/m gradient system. High resolution anatomical scans were obtained 211 
using a T1-weighted three dimensional gradient recalled echo acquisition: 3D T1 fast field 212 
echo sequence on Philips scanner, and 3D T1 fast low angle shot on Siemens scanner, both 213 
with the same acquisition parameters (TE=4.6ms, TR=25ms; flip angle=30º, field of view 214 
on frequency=250 mm, 256x256 matrix, isotropic voxel size 1x1x1 mm). 215 
2.6 VBM analysis 216 
MRI data were analyzed with FSL-VBM, a (Voxel-based Morphometry) VBM 217 
analysis [29, 30] that is part of the FSL software package 218 
(http://www.fmrib.ox.ac.uk/fsl/fslvbm/index.html) [31]. First, tissue segmentation was 219 
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carried out using FMRIB’s Automatic Segmentation Tool (FAST) from brain-extracted 220 
images [32]. The resulting grey matter partial volume maps were then aligned to the 221 
Montreal Neurological Institute standard space (MNI152) using the nonlinear registration 222 
approach using FNIRT [33] which uses a b-spline representation of the registration warp 223 
field [34]. A study-specific template was created, combining AD and Control images, to 224 
which the native gray matter images were re-registered nonlinearly. The registered partial 225 
volume maps were then modulated (to correct for local expansion or contraction), by 226 
dividing them by the Jacobian of the warp field. The modulated images were then 227 
smoothed with an isotropic Gaussian kernel with a sigma of 3mm (FWHM: 8 mm).  228 
The statistical analysis was performed via a voxel wise general linear model (GLM) 229 
to investigate gray matter intensity differences. Permutation-based nonparametric testing 230 
(with 5000 permutations per contrast) [35] was used to form clusters with the threshold-free 231 
cluster enhancement (TFCE) method [31]. The significance threshold was p < 0.05 and 232 
tests were corrected for multiple comparisons via Family-wise Error (FWE) correction 233 
across space, unless otherwise stated. For uncorrected results, a threshold of 100 contiguous 234 
voxels was used, at p < 0.001 to reduce the likelihood of significant clusters. Regions of 235 
significant atrophy were superimposed on the MNI standard brain, with maximum 236 
coordinates provided in MNI space. Areas of significant gray matter loss were localized 237 
with reference to the Harvard-Oxford probabilistic cortical and subcortical atlas. 238 
In a first step, differences in gray matter intensities between AD patients and HC 239 
were assessed. To control for a possible scanner site effect, we introduced scanner site as a 240 
nuisance covariate for the group contrasts. Next, correlations between gray matter atrophy 241 
and T-ADLQ total score and the scores of the three domains of the T-ADLQ, i.e. BADL, 242 
IADL and a-ADL subscores, were entered as covariates in the design matrix of the VBM 243 
analysis for AD patients combined with HC. This procedure improves the statistical power 244 
to detect brain-behavior relationships[36]. In a third step, we study overlap of brain atrophy 245 
between the BADL, IADL and a-ADL subscores performing an inclusive masking analysis. 246 
For statistical power, a covariate-only statistical model with a t-contrast was used, 247 
providing an index of association between brain atrophy and scores on the functional 248 
scales. The statistical maps generated from the contrast using BADL, IADL and a-ADL 249 
subscores as covariate, were scaled using a threshold of p < 0.001, following which, the 250 
scaled contrasts were multiplied to create an inclusive, or overlap, mask across groups. In a 251 
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fourth step, we performed a contrast analysis between the three subscores BADL, IADL 252 
and a-ADL subscores of the T-ADLQ to study the existence of significant anatomical 253 
differences between the different domains. For the exclusive masks, the same procedure 254 
described above was adopted. However, the scaled images were subsequently subtracted 255 
from each other, to create an exclusive mask for each condition. 256 
3. Result 257 
3.1. Demographic and neuropsychological data 258 
Demographic and neuropsychological scores are shown in Table 2. AD and HC 259 
groups did not differ in terms of sex, age, or education (all p> 0.05). In brief, AD patients 260 
exhibited scores significantly higher on assessments of severity of the disease (CDR) and 261 
lower on measures of global cognitive efficiency (ACE-R-Ch and MMSE) and episodic 262 
memory (FCSRT) relative to HC. Compared to the HC group, the AD group was impaired 263 
on the global scores of T-ADLQ (F(1,67) = 70.981, p< 0.001); the three ADL domains  and 264 
the ICT subscores  (see Table 2) The details of the neuropsychological battery in HC and 265 
AD subjects are shown in Supplementary Table 1. 266 
----- INSERT TABLE 2 BY HERE-------- 267 
3.2. VBM: Groups comparison analysis 268 
Results are shown in Table 3 and Figure 1. The AD group was contrasted with HC 269 
group to reveal patterns of brain atrophy. The AD group showed significant grey matter 270 
atrophy in bilateral hippocampal brain regions, bilateral precentral gyrus, and a right 271 
lateralized atrophy in the precuneus cortex, inferior frontal gyrus (par opercularis), inferior 272 
temporal gyrus and temporal fusiform cortex (posterior division) (Pfwecorr<0.05). Similar 273 
results were obtained in the analysis covarying for scanner site (see Supplementary Table 2 274 
and Supplementary Figure 1). 275 
------- INSERT TABLE 3 BY THERE ----- 276 
------- INSERT FIGURE 1 BY THERE ----- 277 
3.3 Correlations with T-ADLQ subscores 278 
VBM correlations with T-ADLQ total score are presented in supplementary files 279 
(see Supplementary Table 3 and Supplementary Figure 2). In brief, T-ADLQ total score 280 
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covaried with bilateral atrophy in the parahippocampal gyrus (anterior division) and the 281 
inferior temporal gyrus (posterior division and temporo-occipital region), and a right 282 
lateralized atrophy in the lateral occipital cortex (inferior and superior division) (punorr< 283 
0.001).  284 
BADL, IADL and a-ADL subscores of the T-ADLQ were entered as covariate in 285 
the design matrix of the VBM analysis. Results are shown in Table 4 and Figure 2.  For the 286 
AD group, the score on the BADL domain covaried with atrophy in the left supplementary 287 
motor cortex and right frontal regions (orbital cortex and superior/middle frontal gyrus) 288 
(punorr< 0.001). The IADL subscore covaried with atrophy in several areas widely 289 
distributed, highlighting the left paracingulate gyrus, bilateral temporal fusiform cortex, left 290 
parahippocampal gyrus (anterior division), and right intracalcarine cortex (punorr< 0.001). 291 
Finally, the a-ADL score covaried mainly with atrophy in the left lingual gyrus, 292 
intracalcarine cortex, and bilateral parahippocampal gyrus (anterior division) (punorr<0.001).   293 
We present the VBM results showing regions of significant gray matter intensity decrease 294 
that covary with the ICT subscale in supplementary material (see Supplementary Table 4 295 
and Supplementary Figure3). 296 
------- INSERT TABLE 4 BY THERE ----- 297 
------- INSERT FIGURE 2 BY THERE ----- 298 
3.4 Overlap analysis 299 
We performed an inclusive masking analysis to verify which areas of brain atrophy 300 
overlap when accounting for functional impairment in AD as measured by IADL domain 301 
vs. a-ADL domain and BADL domain and a-ADL domain. Results show that the BADL 302 
domain overlap with neither the IADL nor the a-ADL domain subscores of the T-ADLQ.  303 
We found an overlap between the IADL and a-ADL domain subscores of the T-ADLQ (see 304 
Table 5 and Figure 3). 305 
------- INSERT TABLE 5 BY THERE ----- 306 
------- INSERT FIGURE 3 BY THERE ---- 307 
3.5 Contrast Analysis 308 
In a final step, we performed a contrast analysis between the BADL, IADL and a-309 
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ADL domain subscores of the T-ADLQ to study the existence of significant anatomical 310 
differences between the different domains. Results shows that a-ADL were exclusively 311 
associated with one cluster in the left lingual gyrus and the anterior division of the 312 
parahippocampal gyrus. The score of the IADL covariated exclusively with atrophy in 313 
several areas, mainly the left paracingulate and cingulate gyrus (anterior division), the right 314 
and left temporal fusiform cortex (anterior division) and the right middle frontal gyrus 315 
(puncorr< 0.001) (see Table 6 and Figure 3). 316 
------- INSERT TABLE 6 BY THERE ----- 317 
4. Discussion 318 
To the best of our knowledge, this is the first study assessing the neural correlates of 319 
a-ADL and ICT in AD. Our results showed that T-ADLQ subscores correlate with several 320 
brain structures, with a varying degree of overlap when the three domains of activities of 321 
the questionnaire were considered. The BADL score correlated mostly with frontal atrophy, 322 
IADL with more widespread frontal, temporal and occipital atrophy and a-ADL with 323 
occipital and temporal atrophy. The inclusive masking analysis did not show areas that 324 
overlap between BADL, IADL and a-ADL. However, the bilateral parahippocampal region 325 
(PHR) and the precuneus cortex are implicated in both, the IADL and a-ADL. In the 326 
exclusive masking analysis, we found an association between IADL and the paracingulate 327 
gyrus and the temporal fusiform cortex, while a-ADL correlated more with lingual gyrus 328 
atrophy.  329 
T-ADQL total score correlated with a large cluster centered in the temporal 330 
fusiform cortex (anterior division) and parahippocampal gyrus (anterior division). 331 
Concerning the association with the temporal cortex, our results are in line with studies in 332 
both AD and other neurological disorders. Medial temporal lobe atrophy has been 333 
associated with functional impairment in both, subjects with stroke [37] and mild cognitive 334 
impairment (MCI) [38]. The association with the PHR is not surprising due to the 335 
involvement of the PHR in multiple cognitive process relevant to everyday functioning as 336 
visuospatial processing, episodic memory, and contextual associative processing [39]. 337 
Moreover, PHR atrophy has been reported as an early biomarker of AD [40], and 338 
hypometabolism in this region has been associated with greater decline in IADL 339 
performance [18]. Concerning BADL, AD patients assessed in our study were in mild to 340 
moderate stages of the disease and presented mild impairment in some BADL activities 341 
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(average of 5% of impairment). BADL correlated with two small clusters in left 342 
supplementary motor cortex and right frontal regions (orbital cortex and superior/middle 343 
frontal gyrus). Although we acknowledge that these results should be interpreted with 344 
caution due to the characteristics of our samples, they are in agreement with several studies 345 
which have reported that motor abilities are crucial for BADL[41] [42, 43]and tend to 346 
decline as the disease progresses[44].  347 
IADL correlated with the left paracingulate gyrus, bilateral temporal fusiform 348 
cortex, left parahippocampal gyrus (anterior division), and right intracalcarine cortex, 349 
among others. Our results are in agreement with previous studies on the neural correlates of 350 
IADL [15]. IADL impairment has been associated with inferior temporal and lateral 351 
parietal (supramarginal) atrophy [17], decreased gray matter volume in the medial frontal 352 
and temporo-parietal cortices in early stages of AD [45], and white matter lesion [46]. The 353 
multiple brain areas related with IADL have been attributed to the complex nature of these 354 
activities and their increased demand [15]. 355 
a-ADL correlated with the left lingual gyrus, intracalcarine cortex, and bilateral 356 
parahippocampal gyrus (anterior division), areas that has been associated with higher order 357 
cognitive functions [39], such as explicit memory [47]. As Braak and Braak described, the 358 
brain atrophy of AD patients progresses following a hierarchical model, with early atrophy 359 
in the hippocampus and parahippocampus gyrus [48], linked to memory and visuospatial 360 
impairments in the early stages of the disease, progressing to a generalized pattern of brain 361 
atrophy linked to a wide deterioration of cognitive domains [49]. 362 
In the overlap analysis, we found that the bilateral atrophy of the parahippocampal 363 
gyrus, the paracingulate gyrus, and the intracalcarine cortex are associated to both IADL 364 
and a-ADL impairments. Atrophy of these areas has been associated with impairment in 365 
episodic memory, language, praxis and visual perception. These symptoms appear in the 366 
early stages of AD [47, 50], corresponding to the typical progression of the disease, starting 367 
with impairment in complex cognitive domains, including IADL, to difficulties in BADL in 368 
the most advanced stages [51]. 369 
In the exclusive analysis, we found that left parahippocampal gyrus correlated 370 
exclusively with a-ADL. This area has been extensively associated with topographical 371 
learning and spatial navigation [52-54], and is crucial for normal adaptive behaviors in 372 
work, travelling, or during other activities that comprise a-ADL. 373 
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Finally, we found that the ICT subscale is associated with atrophy in the precuneus, area 374 
that has been related with visuospatial functioning, attentional shift, and processing speed 375 
[55, 56] It has also been considered a higher-order area that is generally involved in 376 
controlling spatial aspects of motor behavior, and episodic memory retrieval[57]. Evidence 377 
shows that attentional and visuospatial abilities are necessary for internet searching [58]. 378 
Attentional engagement had also been described in motor-cognitive skills when working 379 
with touch-screen terminal [59]. Recent evidence suggests that hypometabolism in the 380 
precuneus may be a biomarker of potential progression to AD [60]. From this perspective, 381 
functional changes associated to this region may reflect the earliest manifestations of the 382 
impact of AD on ADL, suggesting that these novel functional assessment tools could be 383 
considered sensitivity tools to aid in the early diagnosis of AD.  Longitudinal studies in AD 384 
and other dementias are mandatory to support this hypothesis. 385 
Our division of the T-ADLQ items in BADL, IADL and a-ADL should be 386 
interpreted with caution as it was performed based on an expert panel in clinical diagnosis 387 
of dementia and research in functional assessment.  Although experts hold experience in 388 
cognitive neurology (AS and CD), neuropsychology (CMN, FH and GF) and occupational 389 
therapy (EM), some of such decisions can be influenced by sociocultural factors. For 390 
example, classification of computer use as an a-ADL and use of mobile phones as an IADL 391 
may not be representative of every socio-cultural or generational context.  The study here 392 
presented was carried out in 2015 when only 10% of the targeted elderly population 393 
reported use of internet, 80% of them had access to the internet via landline connectivity 394 
and only 20% via mobile phones [61, 62].  Moreover, elderly people in Chile, as in other 395 
countries such as Portugal, report that they mainly use mobile phones for basic functions 396 
such as answering and calling[63].  Also,  in a recent paper by our group [64], we provide 397 
additional evidence on the validity of our proposed division of the T-ADLQ in the BADL/ 398 
IADL and a-ADL categories. Nevertheless, further studies need to address the subdomains 399 
characterization of evolving T-ADLQ; and these would need to be updated considering 400 
intra-country specificity and socio-cultural factors [5, 65]. 401 
Some methodological issues warrant consideration. First, our neuroimaging results 402 
regarding the correlation between VBM and subscore domain did not survive conservative 403 
corrections for multiple comparisons and were therefore reported uncorrected at p< 0.001. 404 
However, we reduced the likelihood of false positive results, by applying cluster extent 405 
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thresholds of 100 contiguous voxels in the analysis. Importantly, Monte Carlo simulations 406 
and experimental data demonstrate that cluster thresholding is an effective tool to reduce 407 
the probability of false positive findings without compromising the statistical power of the 408 
study [66]. Given our sample size, the application of stringent cluster extended thresholds, 409 
and our a priori assumptions, we are confident that our results do not represent false 410 
positive findings. However, it will be important to replicate these findings in larger patient 411 
cohorts using corrected neuroimaging approaches. Second, the diagnosis of AD was 412 
established on clinical grounds without any neuropathological confirmation for the 413 
diagnoses. Nevertheless, AD patients presented bilateral atrophy in the hippocampal region, 414 
a structural biomarkers of AD. Moreover, clinical pathological studies suggested that 415 
NINCDS-ADRDA criteria are reliable for the diagnosis of AD. Finally, patients included in 416 
the study fulfilled criteria for Alzheimer’s Clinical Syndrome according to the latest NIA-417 
AA Research Framework [67]. 418 
In conclusion, our study suggests that combining a domain specific approach to 419 
ADL with neuropathological data drawn from MRI, specific functional phenotypes can be 420 
identified. We have demonstrated that in the sample of AD investigated here such a 421 
phenotype is characterized by widespread atrophy of the prefrontal, temporal and occipital 422 
brain regions significantly associated with functional impairments that follow a gradient of 423 
deterioration in the diseases continuum. Such functional phenotypes seemingly inform 424 
about such a continuum. Our data also suggest that ADL assessment via such an approach 425 
can be very sensitive to neurodegenerative processes, and that the association of types of 426 
functional decline and AD progression does follow a traceable neuropathological pathway 427 
that involves different neural network. Our results are consistent with the existence of a 428 
specific pattern of functional loss in the activities of daily living, namely functional 429 
phenotypes, beginning with impairment in the a-ADL, followed by losses in IADL and 430 
finally progressing to BADL[4] .  431 
Further studies need to address the contribution of white matter lesion to functional 432 
impairment[68]. Finally, generalization of our results to other neurodegenerative diseases 433 
should be made with cautious. Nevertheless, futures studies are needed to investigate if 434 
other neurodegenerative disease leads to functional phenotypes different to those seen in 435 
AD. Indeed, ADL dysfunction in FTD is associated with atrophy in network different to 436 
that reported in AD and the left superior frontal gyrus is the only region implicated in IADL 437 
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dysfunction in both FTD and AD [15]. 438 
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Figure 1: VBM showing significant gray matter intensity decrease in AD in contrast HC 
uncorrected by scanner. 
 
VBM analysis showing brain areas of decreased gray matter intensity in AD patients in 
comparison with Controls (MNI coordinates X = -38; Y = -36; Z = -8). Colored voxel show 
regions that were significant in the analysis with P < 0.05 corrected for multiple 
comparisons (family-wise error), with a cluster threshold of 100 contiguous voxels. 
Clusters are overlaid on the MNI standard brain. 
Figure 2.  
VBM correlation with T-ADLQ subscores in AD in comparison with HC uncorrected by 
scanner. 
 
VBM analysis showing brain areas in which gray matter intensity correlates significantly 
with T-ADLQ subscores (A) BADL (MNI coordinates X = 32; Y = 6; Z = 44), (B) IADL 
(MNI coordinates X = -4; Y = -70; Z = -16) and (C) a-ADL subscores (MNI coordinates X 
= 30; Y = -62; Z = 46) in AD in comparison with Controls. Colored voxel show regions 
that were significant in the analysis with P < 0.001 uncorrected. For all analysis, a cluster 
threshold of 100 contiguous voxels was used. Clusters are overlaid on the MNI standard 
brain. 
 
Figure 3.  
VBM overlap and exclusive mask analysis for IADL and a-ADL in AD compared with HC.  
 
VBM analysis showing overlap brain regions between T-ADLQ IADL and a-ADL domain 
sub-scores (green), and regions that correlate exclusively with IADL (red) and a-ADL 
(blue) in AD in comparison with Controls (MNI coordinates X = 30; Y = -62; Z = 40). 
Colored voxel show regions that were significant in the analysis with P < 0.001 
uncorrected. For all analysis, a cluster threshold of 100 contiguous voxels was used. 
Clusters are overlaid on the MNI standard brain. 
 
Table 1  
Division of the three domains of the Technology – Activities of daily living questionnaire 
*. 
Basic ADL Instrumental ADL Advanced ADL 
Eating Taking pills or medicine Employment 
Dressing Handling cash Recreation 
Bathing Managing finances Organization 
Elimination Public transportation Travel 
Interest in personal 
appearance 
Driving Internet access 
 Mobility around the neighborhood Email Access 
 Traveling outside familiar environment Computer use 
 Preparing meals, cooking  
 Setting the table  
 Housekeeping  
 Home maintenance  
 Home repair   
 Laundry  
 Food shopping  
 Using the telephone  
 Talking  
 Understanding  
 Reading  
 Writing  
 Cell phone use  
 ATM use  
* The T-ADLQ scale is presented in supplementary files 
 
Table 2  
Demographic, global cognitive, and functional characteristics of AD and HC.  
 AD Control t-test/χ2 Effect Size1 
(d) 
95% CI 
     Lower Upper 
N 33 29     
Sex (m:f) 13:20 9:20 0.492    
Age (years) 73.09 ± 
6.96 
72.03 ± 
5.99 
0.636 0.163 -2.265 4.378 
Education 
(years) 
12.21 ± 
4.45 
12.59 ± 
3.73 
-0.356 -0.092 -2.476 1.728 
MMSE 20.79 ± 
4.88 (30) 
28.07 ± 
1.67 (30) 
-7.648** -1.996 -9.185 -5.377 
ACE-R 62.24 ± 
15.64 (100) 
92.55 ± 
5.60 (100) 
-9.887** -2.580 -36.441 -24.177 
CDR 1.66 ± 0.65 
(3) 
0 ± 00  
(3) 
13.648** 3.611 1.413 1.899 
CDR-SB 5.84 ± 2.82 
(18) 
0 ± 00  
(18) 
11.157** 2.928 4.796 6.892 
CDR-AlG 1.13 ± 0.83 
(3) 
0 ± 00 
(3) 
7.269** 1.925 0.815 1.435 
T-ADLQ (%) 
Total  
38.00 ± 
16.96 (100) 
8.41 ± 8.90 
(100) 
8.425** 2.184 22.562 36.611 
BADLi 
domain 
subscore  of 
the  T-ADLQ 
(%) 
5.70 ± 
11.56 (100) 
 
 
0.93 ± 2.94 
(100) 
 
2.158* 
 
 
0.565 
 
 
0.347 
 
 
9.184 
 
 
IADL domain 
subscore of 
the  T-ADLQ 
(%) 
43.73 ± 
19.39 (100) 
 
7.79 ± 
10.23 (100) 
 
 
8.939** 
 
 
 
2.318 
 
 
 
27.893 
 
 
 
43.975 
 
 
 
a-ADL 
domain  of the 
T-ADLQ (%) 
52.33 ± 
22.00 (100) 
19.76 ± 
19.85 (100)  
6.087** 1.554 21.869 43.280 
Abbreviations: AD: Alzheimer’s diseases; CDR: Clinical Dementia Rating. CDR-SB: 
Clinical Dementia Rating – Sum of Box. CDR-AlG: Clinical Dementia Rating – Algorithm; 
MMSE: Mini-Mental State Examination; ACE-R: Addenbrooke’s Cognitive Examination 
Revised; MoCA: Montreal Cognitive Assessment; T-ADLQ: Technology of Daily Living 
Questionnaire. i. BADL: Basic Activities of daily life. ii. IADL: Instrumental ADL. iv a-
ADL Advanced Activities of daily life. 
Data are presented in mean ± standard deviation (Total score).  
*p<0.05, **p<0.001. 
 
Table 3. 
VBM showing significant gray matter intensity decrease in AD in contrast HC uncorrected 
by scanner.  
  MNI coordinates  
Regions 
Hemisphere x y z 
Number of 
voxel 
      
Hippocampus Left -24 -34 -10 1513 
Hippocampus Right 24 -36 -8 1155 
Precentralgyrus Left -38 0 28 122 
Precuneous cortex Right 16 -64 32 119 
Inferior frontal gyrus, 
par opercularis / 
precentralgyrus 
Right 36 8 26 117 
Inferior Temporal gyrus 
/ Temporal Fusiform 
cortex, posterior division 
Right 44 -14 -30 111 
All results corrected for multiple comparisons (family-wise error) at P< 0.05; only cluster 
with at least 100 contiguous voxels included. MNI = Montreal Neurological Institute. 
 
Table 4: VBM correlation with T-ADLQ subscores in AD in comparison with HC 
uncorrected by scanner. 
  MNI coordinates  
Regions Hemisphere x y z Numberof voxel 
  BADL IADL a-
ADL 
 
BADLi domain 
subscore 
     
Supplementary 
Motor Cortex 
Left -14 6 50 274 
Frontal orbital 
cortex 
Right 32 28 0 260 
Superior frontal 
gyrus / Middle 
frontal gyrus 
Right 24 26 44 139 
IADLii domain 
subscore  
     
Para cingulate 
gyrus 
Left -4 34 26 3363 
Temporal 
fusiform cortex, 
anterior division 
Right 32 -2 -40 1936 
Temporal Left -28 -10 -38 1418 
fusiform cortex / 
Parahippocampal 
gyrus, anterior 
division 
Intracalcarine 
cortex 
Right 8 -66 12 836 
Frontal 
operculumcortex 
/ Central 
opercular córtex 
Right 42 10 10 512 
Parahippocampal 
gyrus, posterior 
division /  
Temporal 
fusiform cortex, 
posterior division 
Left -32 -34 -16 379 
Intracalcarine 
cortex 
Left -12 -70 10 191 
Precentral gyrus Left -38 0 22 185 
Lateral occipital 
cortex, inferior 
division 
Right 34 -78 10 146 
Lingual gyrus / Right 20 -74 -6 107 
Occipital 
fusiform gyrus 
Superior parietal 
lobule / Angular 
gyrus 
Right 32 -50 42 101 
a-ADLiii  domain 
subscore 
     
Lingual gyrus / 
Intracalcarine 
cortex 
Left -14 -62 4 1379 
Parahippocampal 
gyrus, anterior 
division 
Left -24 -10 -38 1169 
Parahippocampal 
gyrus, anterior 
division 
Right 30 -14 -28 732 
Paracingulate 
gyrus 
Left -12 28 32 324 
Superior frontal 
gyrus 
Right 12 10 58 175 
Superior frontal 
gyrus 
Left -18 8 46 131 
Paracingulate Right 12 30 40 107 
gyrus / Superior 
frontal gyrus 
Paracingulate 
gyrus 
Right 4 26 40 106 
. i. BADL: Basic ADL. ii. IADL : Instrumental ADL. iii: a-ADL Advanced ADL 
All results uncorrected at P< 0.001. Only cluster with at least 100 contiguous voxels 
included. MNI = Montreal Neurological Institute. 
 
Table 5. VBM overlap between IADL and a-ADL subscores in AD compared with HC 
uncorrected by scanner. 
  MNIcoordinates  
 
Regions 
 
Hemisphe
re 
 
x 
 
y 
 
z 
Number 
of voxel 
Regions of overlap      
Parahippocampal 
gyrus, anterior 
division 
Right 30 -14 -28 471 
Precuneous cortex Right 14 -56 12 463 
Parahippocampal 
gyrus, anterior 
division 
Left -28 -12 -36 373 
Parahippocampal 
gyrus, posterior 
division 
Left -28 -36 -14 232 
Paracingulate 
gyrus 
Left -10 28 36 191 
Intracalcarine 
cortex 
Left -12 -68 10 108 
All results uncorrected at P< 0.001. Only cluster with at least 100 contiguous voxels 
included. MNI = Montreal Neurological Institute. 
Table 6.  
VBM exclusive regions that correlate with IADL and a-ADL subscores in AD compared 
with HC. 
  MNI coordinates  
Regions Hemisphere x y z Number of voxel 
IADLi domain 
subscores 
     
Paracingulate 
gyrus / Cingulate 
gyrus, anterior 
division 
Left -8 36 22 1930 
Temporal 
fusiform cortex, 
anterior division 
Right 30 -2 -42 1258 
Temporal 
fusiform cortex, 
anterior division 
Left -30 0 -40 862 
Middle frontal 
gyrus 
Right 26 26 40 731 
Central 
operculum cortex  
Right 42 8 10 482 
Precuneous 
cortex 
Right 18 -58 20 242 
Central 
operculum cortex 
Left -36 0 20 185 
Lateral occipital 
cortex, inferior 
division 
Right 36 -82 8 146 
Occipital 
fusiform gyrus 
Right 26 -66 -8 107 
a-ADLii domain  
subscores 
     
Lingual gyrus Left -16 -62 2 646 
Parahippocampal 
gyrus, anterior 
division 
Left -20 -10 -40 340 
ii IADL : Instrumental ADL. ii: a-ADL: Advanced ADL 
All results uncorrected at P < 0.001. Only cluster with at least 100 contiguous voxels 
included. MNI = Montreal Neurological Institute. 
 
